Asthma as A Comorbid Disease in COVID-19 | Zendy

Ayşe Baççıoğlu | Zendy; Sevim Bavbek | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Asthma as A Comorbid Disease in COVID-19

Author(s) -

Ayşe Baççıoğlu,

Sevim Bavbek

Publication year - 2020

Publication title -

asthma allergy immunology

Language(s) - English

Resource type - Journals

ISSN - 1308-9234

DOI - 10.21911/aai.565

Subject(s) - asthma , exacerbation , medicine , pandemic , covid-19 , asthma exacerbations , comorbidity , coronavirus , disease , immunology , intensive care medicine , infectious disease (medical specialty) , virology , outbreak

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus disease 2019 (COVID-19). In terms of asthma and COVID-19, there is also a risk of experiencing an asthma exacerbation triggered by coronavirus infection beyond the direct risk of the infection itself. As a comorbid disease, the prevalence of COVID-19 infection in asthma patients is not clear. In addition, the influence of asthma on the severity of COVID-19 has not been reported. The aim of this review was to summarize the reported worldwide data about the prevalence and the clinical characteristics of patients with asthma during COVID-19 infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research